Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Neumann

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Plos One|December 27, 2018
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibilityDavid González-Serna, Elio G Carmona, Norberto Ortego-Centeno, et al.
Scientific Reports|November 20, 2019
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated DysfunctionsGergely Tóth, Thomas Neumann, Amandine Berthet, et al.
Nature Reviews. Rheumatology|May 10, 2023
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitisGiacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Journal of Fungi (Basel, Switzerland)|October 8, 2020
Spread of Terbinafine-Resistant <i>Trichophyton mentagrophytes</i> Type VIII (India) in Germany-"The Tip of the Iceberg?"Pietro Nenoff, Shyam B Verma, Andreas Ebert, et al.
The New England Journal of Medicine|July 20, 2012
Genetically distinct subsets within ANCA-associated vasculitisPaul A Lyons, Tim F Rayner, Sapna Trivedi, et al.
Nature Communications|November 14, 2019
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA statusPaul A Lyons, James E Peters, Federico Alberici, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Plos One|December 27, 2018
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibilityDavid González-Serna, Elio G Carmona, Norberto Ortego-Centeno, et al.
Scientific Reports|November 20, 2019
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated DysfunctionsGergely Tóth, Thomas Neumann, Amandine Berthet, et al.
Nature Reviews. Rheumatology|May 10, 2023
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitisGiacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Journal of Fungi (Basel, Switzerland)|October 8, 2020
Spread of Terbinafine-Resistant <i>Trichophyton mentagrophytes</i> Type VIII (India) in Germany-"The Tip of the Iceberg?"Pietro Nenoff, Shyam B Verma, Andreas Ebert, et al.
The New England Journal of Medicine|July 20, 2012
Genetically distinct subsets within ANCA-associated vasculitisPaul A Lyons, Tim F Rayner, Sapna Trivedi, et al.
Nature Communications|November 14, 2019
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA statusPaul A Lyons, James E Peters, Federico Alberici, et al.
Pageof 27